ArticleOncotarget2014

B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells.

Wynand P Roos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.